Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

Sugars, primarily glucose and fructose, are the main energy source of cells. Because of their hydrophilic nature, cells use a number of transporter proteins to introduce sugars through their plasma membrane. Cancer cells are well known to display an enhanced sugar uptake and consumption. In fact, su...

Full description

Saved in:
Bibliographic Details
Main Authors: Moisés Blanco Calvo, Angélica Figueroa, Enrique Grande Pulido, Rosario García Campelo, Luís Antón Aparicio
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2010/205357
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554095249981440
author Moisés Blanco Calvo
Angélica Figueroa
Enrique Grande Pulido
Rosario García Campelo
Luís Antón Aparicio
author_facet Moisés Blanco Calvo
Angélica Figueroa
Enrique Grande Pulido
Rosario García Campelo
Luís Antón Aparicio
author_sort Moisés Blanco Calvo
collection DOAJ
description Sugars, primarily glucose and fructose, are the main energy source of cells. Because of their hydrophilic nature, cells use a number of transporter proteins to introduce sugars through their plasma membrane. Cancer cells are well known to display an enhanced sugar uptake and consumption. In fact, sugar transporters are deregulated in cancer cells so they incorporate higher amounts of sugar than normal cells. In this paper, we compile the most significant data available about biochemical and biological properties of sugar transporters in normal tissues and we review the available information about sugar carrier expression in different types of cancer. Moreover, we describe the possible pharmacological interactions between drugs currently used in anticancer therapy and the expression or function of facilitative sugar transporters. Finally, we also go into the insights about the future design of drugs targeted against sugar utilization in cancer cells.
format Article
id doaj-art-7e2ad95df7cf4d3d9af13e94c621fff3
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-7e2ad95df7cf4d3d9af13e94c621fff32025-02-03T05:52:19ZengWileyInternational Journal of Endocrinology1687-83371687-83452010-01-01201010.1155/2010/205357205357Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer TherapyMoisés Blanco Calvo0Angélica Figueroa1Enrique Grande Pulido2Rosario García Campelo3Luís Antón Aparicio4Biomedical Research Institute, A Coruña University Hospital, As Xubias 84, 15006 A Coruña, SpainBiomedical Research Institute, A Coruña University Hospital, As Xubias 84, 15006 A Coruña, SpainClinical Oncology Department, Ramón y Cajal University Hospital, Ctra. de Colmenar Viejo Km. 9,100, 28034 Madrid, SpainClinical Oncology Department, A Coruña University Hospital, As Xubias 84, 15006 A Coruña, SpainClinical Oncology Department, A Coruña University Hospital, As Xubias 84, 15006 A Coruña, SpainSugars, primarily glucose and fructose, are the main energy source of cells. Because of their hydrophilic nature, cells use a number of transporter proteins to introduce sugars through their plasma membrane. Cancer cells are well known to display an enhanced sugar uptake and consumption. In fact, sugar transporters are deregulated in cancer cells so they incorporate higher amounts of sugar than normal cells. In this paper, we compile the most significant data available about biochemical and biological properties of sugar transporters in normal tissues and we review the available information about sugar carrier expression in different types of cancer. Moreover, we describe the possible pharmacological interactions between drugs currently used in anticancer therapy and the expression or function of facilitative sugar transporters. Finally, we also go into the insights about the future design of drugs targeted against sugar utilization in cancer cells.http://dx.doi.org/10.1155/2010/205357
spellingShingle Moisés Blanco Calvo
Angélica Figueroa
Enrique Grande Pulido
Rosario García Campelo
Luís Antón Aparicio
Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
International Journal of Endocrinology
title Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
title_full Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
title_fullStr Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
title_full_unstemmed Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
title_short Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy
title_sort potential role of sugar transporters in cancer and their relationship with anticancer therapy
url http://dx.doi.org/10.1155/2010/205357
work_keys_str_mv AT moisesblancocalvo potentialroleofsugartransportersincancerandtheirrelationshipwithanticancertherapy
AT angelicafigueroa potentialroleofsugartransportersincancerandtheirrelationshipwithanticancertherapy
AT enriquegrandepulido potentialroleofsugartransportersincancerandtheirrelationshipwithanticancertherapy
AT rosariogarciacampelo potentialroleofsugartransportersincancerandtheirrelationshipwithanticancertherapy
AT luisantonaparicio potentialroleofsugartransportersincancerandtheirrelationshipwithanticancertherapy